Back to BARCLAYS PLC BARCLAYS PLC

ADMAADMA

Showing 8 of 31 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in ADMA BIOLOGICS INC

Yes. Barclays holds 86,894 shares of ADMA (Adma Biologics), worth $727,303, as of its Q2 2026 13F filing. It reduced the position by 56,968 shares (-39.6%) from Q1 2026. Barclays has held ADMA in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$727,303

Current Shares

86,894

Total Value Change

-$9.8M

Total Shares Change

-441,735

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
86,894
-39.6%
$727,3030.0%$8.37
0
2026-Q1
Decreased
143,862
-77.8%
$1.3M0.0%$9.01
0
2025-Q4
Decreased
649,100
-15.0%
$11.8M0.0%$18.24
0
2025-Q3
Decreased
763,946
-4.3%
$11.2M0.0%$14.66
0
2025-Q2
Increased
798,720
+79.1%
$14.5M0.0%$18.21
43
2025-Q1
Decreased
445,883
-17.6%
$8.8M0.0%$19.84
0
2024-Q4
Increased
541,093
+2.4%
$9.3M0.0%$17.15
28
2024-Q3
Increased
528,629
+192.2%
$10.6M0.0%$19.99
45

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used